Search

Meeting Coverage:

American Glaucoma Society

AGS: 2020

Rapid Clinical Trials for Neuroprotection

Yvonne Ou, MD

Show Description +

Yvonne Ou, MD, discusses factors to consider in designing rapid clinical trials for neuroprotection. Dr. Ou details novel concepts and technologies that can be incorporated into these trials and shares some updates from her group's work on visual field assessment.

Posted: 1/28/2020

Keywords:

Clinical Cases

•

Neuroprotection

•

Technology

•

visual field testing

Up Next

MIGS in Kids

James D. Brandt, MD, Sarwat Salim, MD

Corneal Hysteresis and Glaucoma Surgery

Corneal Hysteresis and Glaucoma Surgery

Davinder S. Grover, MD, MPH

Autonomous AI's Potential in Glaucoma

Autonomous AI's Potential in Glaucoma

Michael D. Abramoff, MD, PhD

$Glaucoma in Post-Refractive Surgery Eyes$

Glaucoma in Post-Refractive Surgery Eyes

Sarwat Salim, MD

MIGS in the Highly Myopic Patient

MIGS in the Highly Myopic Patient

Constance Okeke, MD, MSCE

LiGHT: Efficacy and Cost Effectiveness

LiGHT: Efficacy and Cost Effectiveness

Gus Gazzard, MD, FRCOphth, Sarwat Salim, MD

Traditional Surgery in the Highly Myopic Patient

Traditional Surgery in the Highly Myopic Patient

Leon Herndon, MD

AI for the Detection of Glaucomatous Progression

AI for the Detection of Glaucomatous Progression

Tobias Elze, PhD

Glaucoma and the Ocular Surface

Glaucoma and the Ocular Surface

Laura A. Voicu, MD, Sarwat Salim, MD

MIGS in the Highly Hyperopic Patient

MIGS in the Highly Hyperopic Patient

Leonard K. Seibold, MD,

OHTS: 20-Year Follow-Up

OHTS: 20-Year Follow-Up

Eve Higginbotham, MD

Founding a Glaucoma Society

Founding a Glaucoma Society

M. Bruce Shields, MD, Sarwat Salim, MD

Classification and Staging of Glaucoma

Classification and Staging of Glaucoma

M. Bruce Shields, MD, Sarwat Salim, MD

Back to All Videos

Rapid Clinical Trials for Neuroprotection

Yvonne Ou, MD

Yvonne Ou, MD, discusses factors to consider in designing rapid clinical trials for neuroprotection. Dr. Ou details novel concepts and technologies that can be incorporated into these trials and shares some updates from her group's work on visual field assessment.

Posted: 1/28/2020

Keywords:

Clinical Cases

•

Neuroprotection

•

Technology

•

visual field testing

Please log in to leave a comment.

More From AGS: 2020 Coverage

OHTS: 20-Year Follow-Up

OHTS: 20-Year Follow-Up

Eve Higginbotham, MD

Founding a Glaucoma Society

Founding a Glaucoma Society

M. Bruce Shields, MD, Sarwat Salim, MD

Classification and Staging of Glaucoma

Classification and Staging of Glaucoma

M. Bruce Shields, MD, Sarwat Salim, MD

MIGS in Kids

MIGS in Kids

James D. Brandt, MD, Sarwat Salim, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2020.